Skip to the content
Caishen.CoCaishen.Co
Primary Data for China's Secondary Investment and Stock Markets
  • Login
  • About
  • FAQ
  • Login
  • About
  • FAQ
  • Twitter
  • LInkedIn

SZSE Ticker: 002603

Shijiazhuang Yiling Pharmaceutical Co., Ltd

石家庄以岭药业股份有限公司

以岭药业

YILING

Listing Date: 2011-07-28

Board: SME

Industry Classification: Manufacturing

A number of companies have clarified that "there is no fenugreek"! Beware of second-degree speculation in risk concept stocks_Sina Finance_Sina.com

  • Post date May 17, 2022 — 15:02 Post Lock Login to View

Read More

A number of companies have clarified that "there is no fenugreek"! Beware of the risk of second-degree speculation CFi.CN Zhongcai Network

  • Post date May 17, 2022 — 14:57 Post Lock Login to View

Read More

A number of companies have clarified that "there is no fenugreek"! Beware of the risk of second-degree speculation

  • Post date May 17, 2022 — 14:10 Post Lock Login to View

Read More

A number of companies have clarified that "there is no fenugreek"! Beware of the risk of second-degree speculation

  • Post date May 17, 2022 — 12:42 Post Lock Login to View

Read More

Changsheng Medical Quantitative Stock Net Worth Down 3.31% Changsheng_Sina Finance_Sina Network

  • Post date May 17, 2022 — 09:00 Post Lock Login to View

Read More

Changsheng Competitive Advantage Stock C Net Worth Down 3.04% Changsheng_Sina Finance_Sina Net

  • Post date May 17, 2022 — 09:00 Post Lock Login to View

Read More

Changsheng Competitive Advantage Stock A Net Worth Down 3.03%

  • Post date May 17, 2022 — 09:00 Post Lock Login to View

Read More

The mixed net worth of Changsheng Pension and Health fell 3.17%.

  • Post date May 17, 2022 — 09:00 Post Lock Login to View

Read More

More than 1,200 companies held a performance briefing on the Shanghai stock market that will last until June "in full swing"

  • Post date May 17, 2022 — 07:53 Post Lock Login to View

Read More

Jin Aobo (002917): Record Form of Investor Relations Activities on May 13, 2022 CFi.CN Zhongcai Network

  • Post date May 17, 2022 — 00:56 Post Lock Login to View

Read More

10-Year Treasury Yield Approaches High, Growth and Dividend Stocks to Benefit

  • Post date May 16, 2022 — 20:48 Post Lock Login to View

Read More

Yiling Pharmaceutical: At present, the company has not deployed hepatitis-related drug research and development_Oriental Fortune Network

  • Post date May 16, 2022 — 19:29 Post Lock Login to View

Read More

Yiling Pharmaceutical: The company's current production, sales, scientific research and other work are normal_Oriental Fortune Net

  • Post date May 16, 2022 — 19:29 Post Lock Login to View

Read More

The main capital of 32.2 billion has withdrawn from the concept stocks of margin financing and securities lending in the past three days – yqqlm

  • Post date May 16, 2022 — 19:26 Post Lock Login to View

Read More

The top 20 stocks with outflow of funds from individual stocks in the two cities-

  • Post date May 16, 2022 — 17:27 Post Lock Login to View

Read More

Zhongsheng Ruichuang's 3CL protease inhibitor clinical trial application was accepted by NMPA, and domestic new crown drugs accelerated

  • Post date May 16, 2022 — 08:44 Post Lock Login to View

Read More

China Pacific Insurance Property & Casualty's Lingang New Area Branch takes the lead in resuming business

  • Post date May 14, 2022 — 12:41 Post Lock Login to View

Read More

Yiling Pharmaceutical Wu Family Wealth Empire: The Gold Master Behind Jia Nailiang? __Chinese Medical

  • Post date May 14, 2022 — 11:02 Post Lock Login to View

Read More

Northbound capital trends exposed: These 30 stocks were sold on May 13

  • Post date May 14, 2022 — 09:00 Post Lock Login to View

Read More

Northbound capital trends exposed: These 30 stocks were sold on May 13

  • Post date May 14, 2022 — 09:00 Post Lock Login to View

Read More

Want to see more data? Registered subscribers can see all the data.

   Register Now!
  • Twitter
  • LInkedIn
  • About Us
  • Contact Us
  • FAQ
  • Privacy Policy
  • Terms and Conditions
  • Corporate Subscription

Copyright © 2025 Caishen.Co. All rights reserved.

To the top ↑ Up ↑
China Money NetworkA service of China Money Network Ltd.